there are about 2~3 full-time management teams of gaoling capital in the secondary market. In addition to the investment team at the front desk, Gao Ying also has a value creation team of about 2 people, who "empower strategy and value" for the invested enterprises. ?

relevant persons of gaoling capital said during the channel roadshow that the entire business segment of gaoling capital is divided into primary and secondary market investments, and the two investments are completely opposite.

Among them, Zhuhai Gaoying is a private equity fund manager who invests in the primary market, while Liren Investment is a private equity securities manager who invests in the secondary market, and the two managers are in a parallel relationship.

48-year-old Zhang Lei is the most influential investor in the domestic equity market. But it started from the secondary market.

in 25, Zhang lei founded gaoling capital as the founder, and the first fund was invested by David swensen, a value investor with the same reputation as Buffett. The initial capital was USD 3 million, and Zhang Lei bought it all into Tencent.

in September 26, gaoling capital officially entered a shares, which were mainly QFII (qualified foreign institutional investors) funds at that time.

in 21, gaoling capital began to open a new primary market investment business, with its first investment in JD.COM.

At present, the asset management scale of Gaochun has reached US$ 65 billion, making it one of the largest investment institutions in Asia. The management scale of Gaochun Capital in A-shares exceeds RMB 1 billion.

Of the asset management scale of Gaochun Capital, which exceeds $65 billion, about 35 billion (more than 5%) comes from private equity investment, among which, the scale of overseas funds is about $2 billion, and the overseas markets mainly invest in US stocks, Hong Kong stocks and other capital markets.

because it doesn't raise funds, the securities investment performance of gaoling capital has always been mysterious. in February this year, its performance was finally rarely exposed, which was quite amazing.

by the end of the first quarter of 22, gaoling capital-HCM fund appeared in the top ten tradable shares of five companies, namely Gree Electric, Aier Ophthalmology, Tiger Medicine, CONCH and Kailitai.

In addition, on the evening of May 12th this year, Kailitai, a company in the field of orthopedics and sports medicine, issued a plan for non-public offering of shares. Among them, Gaochun Capital plans to subscribe for 21 million shares at an issue price of 18.73 yuan/share. It is estimated that Gaochun Capital will subscribe for shares with a total price of 393 million yuan.

At the same time of selling Kailitai, the cooperation between Gao Ling and Gloria Ying is also a step closer. Gloria Ying announced a non-public offering of 17.8 million shares, which was targeted at Gaoying Capital. The fundraising did not exceed 2.31 billion yuan, and the issue price was 123.56 yuan/share, which was 65% off the closing price of 187.95 yuan on May 12.